BALFX
Price
$36.08
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
MBBRX
Price
$12.20
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

BALFX vs MBBRX

Header iconBALFX vs MBBRX Comparison
Open Charts BALFX vs MBBRXBanner chart's image
American Funds American Balanced F1
Price$36.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MassMutual Balanced R4
Price$12.20
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BALFX vs MBBRX Comparison Chart
Loading...
VS
BALFX vs. MBBRX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a StrongBuy and MBBRX is a Buy.

FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 234B vs. MBBRX (107M). BALFX pays higher dividends than MBBRX: BALFX (2.21) vs MBBRX (1.34). BALFX was incepted earlier than MBBRX: BALFX (24 years) vs MBBRX (10 years). BALFX is a more actively managed with annual turnover of: 171.00 vs. MBBRX (155.00). MBBRX has a lower initial minimum investment than BALFX: MBBRX (0) vs BALFX (250). BALFX (20.93) and MBBRX (20.85) have marching annual gain over last year. BALFX return over 5 years is better than : 37.41 vs. MBBRX (10.98).
BALFXMBBRXBALFX / MBBRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years10 years-
Gain YTD12.70213.20296%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets234B107M218,692%
Annual Yield % from dividends2.211.34166%
Returns for 1 year20.9320.85100%
Returns for 3 years12.28-10.75-114%
Returns for 5 years37.4110.98341%
Returns for 10 years50.649.03561%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUE142.980.80
+0.56%
Nucor Corp
PECO38.46-0.03
-0.08%
Phillips Edison & Company
TVTX14.35-0.05
-0.35%
Travere Therapeutics
QUAD4.39-0.06
-1.35%
QUAD/GRAPHICS
INKT0.74-0.01
-1.35%
MiNK Therapeutics